Research programme: pain therapeutics - SRI InternationalAlternative Names: Nociceptin agonists - SRI International; Nociceptin antagonists - SRI International; NOP agonists - SRI International; NOP antagonists - SRI International; SR 14148; SR 14150; SR 16430; SR 16435; SR 165606
Latest Information Update: 16 Jul 2016
At a glance
- Originator SRI International
- Class Small molecules
- Mechanism of Action Nociceptin receptor agonists; Nociceptin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA (Injection)
- 02 Nov 2006 Preclinical trials in Pain in USA (Injection)